Amedisys, Inc. (NASDAQ:AMED) Shares Acquired by Vanguard Group Inc.

Vanguard Group Inc. increased its stake in shares of Amedisys, Inc. (NASDAQ:AMED) by 0.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,241,160 shares of the health services provider’s stock after acquiring an additional 12,137 shares during the quarter. Vanguard Group Inc. owned about 9.93% of Amedisys worth $302,724,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Teachers Retirement System of The State of Kentucky increased its position in shares of Amedisys by 96.9% during the third quarter. Teachers Retirement System of The State of Kentucky now owns 10,922 shares of the health services provider’s stock worth $1,020,000 after purchasing an additional 5,375 shares in the last quarter. Hudson Bay Capital Management LP lifted its stake in Amedisys by 926.5% in the third quarter. Hudson Bay Capital Management LP now owns 166,456 shares of the health services provider’s stock valued at $15,547,000 after buying an additional 150,240 shares during the last quarter. Carmignac Gestion boosted its holdings in shares of Amedisys by 373.2% in the third quarter. Carmignac Gestion now owns 33,725 shares of the health services provider’s stock valued at $3,150,000 after acquiring an additional 26,598 shares during the period. Public Employees Retirement System of Ohio grew its position in shares of Amedisys by 50.7% during the third quarter. Public Employees Retirement System of Ohio now owns 22,563 shares of the health services provider’s stock worth $2,107,000 after acquiring an additional 7,592 shares during the last quarter. Finally, Morgan Stanley increased its holdings in shares of Amedisys by 17.8% in the 3rd quarter. Morgan Stanley now owns 236,823 shares of the health services provider’s stock valued at $22,119,000 after acquiring an additional 35,782 shares during the period. 94.36% of the stock is owned by hedge funds and other institutional investors.

Amedisys Price Performance

Shares of AMED opened at $92.46 on Thursday. The company has a current ratio of 1.05, a quick ratio of 1.05 and a debt-to-equity ratio of 0.32. The stock’s 50 day moving average is $93.61 and its two-hundred day moving average is $93.60. Amedisys, Inc. has a twelve month low of $71.19 and a twelve month high of $96.44. The firm has a market capitalization of $3.02 billion, a PE ratio of -298.25, a P/E/G ratio of 4.34 and a beta of 0.86.

Amedisys (NASDAQ:AMED) last posted its quarterly earnings results on Wednesday, February 21st. The health services provider reported $0.94 EPS for the quarter, missing the consensus estimate of $1.04 by ($0.10). The business had revenue of $570.79 million during the quarter, compared to analyst estimates of $566.85 million. Amedisys had a negative net margin of 0.44% and a positive return on equity of 12.76%. The firm’s quarterly revenue was up 1.6% compared to the same quarter last year. During the same period in the prior year, the business earned $1.16 earnings per share. Research analysts anticipate that Amedisys, Inc. will post 4.54 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on the stock. Raymond James reiterated a “market perform” rating on shares of Amedisys in a research note on Tuesday. StockNews.com began coverage on Amedisys in a report on Saturday, March 23rd. They set a “buy” rating on the stock. Finally, Royal Bank of Canada upped their price objective on Amedisys from $97.00 to $100.00 and gave the company an “outperform” rating in a research note on Monday. Seven research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $97.50.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.